COVID19

MPR Weekly Dose Podcast Episode 32

There has been a lot of recent developments in possible COVID-19 treatments. We cover the latest status with remdesivir, hydroxychloroquine, sarilumab, and remestemcel-L, and also the treatment guidelines for COVID-19 issued by the National Institute of Health.

Pipeline: Investigational Vaccines for COVID-19

Updated on 6/16 While no specific treatment for coronavirus disease 2019 (COVID-19) is currently available, several therapies are being investigated globally.*    Vaccines Altimmune Inc: developing a single-dose, intranasal vaccine against COVID-19 using its proprietary NasoVAX technology. The vaccine is moving toward animal testing. Continue Reading Applied DNA Sciences: collaborating with Takis Biotech to develop a DNA…

Pipeline: Immunotherapies and Other Investigational Therapies for COVID-19

Updated on 6/16 While no specific treatment for coronavirus disease 2019 (COVID-19) is currently available, several therapies are being investigated globally.*    AB201 (ARCA biopharma): a selective inhibitor of tissue factor being developed as a potential treatment for COVID associated coagulopathy. Clinical testing is expected to begin in the second half of 2020. Acalabrutinib (AstraZeneca): a…

Pipeline: Investigational Antiviral Therapies for COVID-19

Updated on 6/16 While no specific treatment for coronavirus disease 2019 (COVID-19) is currently available, several therapies are being investigated globally.*    Antivirals Ampligen (AIM ImmunoTech): a broad-spectrum antiviral being developed for COVID-19 in Japan. A significant survival effect was observed in a trial evaluating mice infected with the earlier Severe Acute Respiratory Syndrome (SARS) coronavirus. Continue…